Renal replacement is a therapy used to exchange the normal blood-filtering function of the kidneys. It plays a vital role in treating severe acute kidney injuries and end-stage kidney diseases. Renal replacement therapy are of three types, which includes peritoneal dialysis, intermittent hemodialysis, and continuous renal replacement therapy.
Continuous renal replacement therapy is a treatment given to the patients with acute kidney injury, particularly for hemo-dynamically unstable cases. Continuous renal replacement therapy involves hemodialysis, hemofiltration or a combination of both. The continuous renal replacement therapy differs from the conventional renal replacement therapies where intermittent hemodialysis lasts for six hours. However, continuous renal replacement therapy last for 24 hours. Removal of fluid or solute at the slower rate per unit time is the major advantage of continuous renal replacement therapy. Therefore, continuous renal replacement therapy is largely accepted than the conventional therapies involving intermittent hydrolysis globally.
Rising incidence of chronic kidney disease to boost the growth of continuous renal replacement therapy market
The major factors contributing the growth of continuous renal replacement therapy market is rising incidence of chronic kidney disease, which is a major risk factor for diabetes, hypertension, cardiovascular disease, and inflammatory disease of the kidney called glomerulonephritis. According to National Center for Biotechnology Information (NCBI) in 2014, around 200 million people were diagnosed with chronic kidney disease, which may lead to the complete loss of renal failure or kidney injury and can also result in end stage renal disease if left untreated. Thereby, requiring continuous renal replacement therapy. The other factors driving the growth of continuous renal replacement therapy market are rise in the number of acute kidney injury cases and other technological advancements in the field of pediatric, such as Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIUM) for the treatment of acute kidney injury in small infants. However, reimbursement, procedural costs, and high complexity of continuous renal replacement therapy, and dearth of trained nurses are the factors that are restraining the growth of continuous real replacement therapy market.
Continuous Renal Replacement Therapy Market Taxonomy
Continuous renal replacement therapy market can be segmented on the basis of product, modality, end user, and geography.
On the basis of product, continuous renal replacement therapy market is segmented into:
On the basis of modality, continuous renal replacement therapy market is segmented into:
On the basis of end user, continuous replacement therapy market is segmented into:
On the basis of region, continuous renal replacement therapy market is segmented into North America, Latin America, Europe, Asia pacific, Middle East, and Africa. North America is expected to dominate the global continuous renal replacement therapy market, owing to the rising incidences of chronic kidney disease. According to American Kidney Fund, in 2015, around 31 million people were diagnosed with chronic kidney disease and it is the ninth leading cause of death in the U.S. Moreover, an innovative technology called wearable artificial kidney launched in the U.S, in 2015 has been designed to provide continuous renal replacement 24 hours a day thus providing feasibility and affordability to the patients. Furthermore, Asia Pacific is expected to emerge as the most lucrative market for continuous renal replacement therapy over the forecast period due to continuous rise in investments aimed at improving health care infrastructure and high unmet medical needs pertaining to target disease, such as hypertension and diabetes.
Innovative Multifiltrate PRO launched by Fresenius Medical care AG &Co. KGaA to boost the growth of continuous renal replacement therapy market
The key players in the continuous renal replacement therapy market are Baxter International, Nikkiso Co. Ltd., B. Braun Melsungen AG, Bellco S.r.I, NxStage Medical, Asahi Kasei corporation, Medica S.P.A, Toray Medical Co., Nipro Corporation, Medtronic Plc, and Dialysis Solutions Inc. The key players are focusing on strategic mergers and acquisition and development of innovative therapy systems. For instance, Fresenius Medical Care AG & Co. KGaA, in May 2015, launched a new therapy system named Multifiltrate PRO for continuous renal replacement therapy and also for the acute kidney failure.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.